Document Detail


Allopurinol as a potential therapeutic agent for recurrent herpes labialis.
MedLine Citation:
PMID:  12968636     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recurrent herpes labialis (RHL) occurs in up to 40% of the population. Although the disease is usually self-limiting, patients seek treatment because of the significant pain and visibility of the lesion. Xanthine oxidase inhibitors (XOI) have been reported to have a potent antiviral effect against influenza-A virus. We examined the effect of the systemic xanthine oxidase inhibitor, allopurinol, on RHL duration of illness, severity of symptoms, number and frequency of recurrence during a 4-year follow up period in Egyptian patients. Duration of illness was shortened by about 25%, early disappearance of pain and other symptoms occurred. Also, aborted episodes were noticed when allopurinol was given just after beginning of common colds, at the prodromal stage of RHL or during severe stress conditions. Patients receiving 3 courses of treatment had markedly decreased recurrences during the follow up period. Ex vivo experiments to examine virus-induced plaque formation on Vero cells in the absence or presence of different concentrations of the drug could not prove any direct anti herpetic effect of the drug. However, allopurinol seems to be safe and effective in reducing duration of RHL and to abort lesion or prevent its appearance in treated patients even when they experience immunosuppressive conditions.
Authors:
Mohamed A El-Farrash; Jilan M Youssef; Shaymaa E El-Mongy
Related Documents :
10809856 - Once weekly fluconazole is effective in children in the treatment of tinea capitis: a p...
6187216 - Combination therapy for dendritic keratitis with human leukocyte interferon and acyclovir.
12971556 - Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-tri...
9487456 - Sputum microscopy results at two and three months predict outcome of tuberculosis treat...
19152906 - The use of carbon dioxide for insufflation during gi endoscopy: a systematic review.
10892856 - Fine needle diathermy occlusion of corneal vessels.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of medical and dental sciences     Volume:  50     ISSN:  1342-8810     ISO Abbreviation:  J. Med. Dent. Sci.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-09-12     Completed Date:  2003-11-03     Revised Date:  2010-04-12    
Medline Journal Info:
Nlm Unique ID:  9717112     Medline TA:  J Med Dent Sci     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  147-54     Citation Subset:  D; IM    
Affiliation:
Department of Medical Microbiology & Immunology, Faculty of Medicine, Mansoura University, Mansoura, Egypt. mfarash@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Allopurinol / pharmacology,  therapeutic use*
Animals
Antiviral Agents / pharmacology,  therapeutic use*
Cercopithecus aethiops
Enzyme Inhibitors / pharmacology,  therapeutic use*
Female
Herpes Labialis / drug therapy*
Herpesvirus 1, Human / drug effects
Humans
Male
Middle Aged
Recurrence / prevention & control
Vero Cells
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/Enzyme Inhibitors; 315-30-0/Allopurinol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of chloramines and sodium hypochlorite on carious dentin.
Next Document:  Coordinated regulation of the promoter and enhancer regions of human CD23 gene by signal through IL-...